161
Participants
Start Date
September 30, 2012
Primary Completion Date
April 30, 2014
Study Completion Date
July 31, 2014
Ceftaroline fosamil
"Treatment Group 1:~Drug: Ceftaroline fosamil Children ≥ 6 months: IV ceftaroline fosamil 12 mg/kg for subjects weighing ≤ 33 kg or 400 mg for subjects weighing \> 33 kg will be infused over 60 (± 10) minutes every 8 hours (q8h) (± 1 hour)~Children \< 6 months: Ceftaroline fosamil 8 mg/kg over 60 (± 10) minutes q8h (± 1 hour)"
Ceftriaxone
"Treatment group 2:~75 mg/kg/day up to 4 g/day IV in equally divided doses, each infused over 30 (± 10) minutes q12hr (± 2 hours)"
amoxicillin clavulanate
"Oral Switch for Treatment Groups 1 and 2:~PO amoxicillin clavulanate 90 mg/kg/day divided q12h in subjects with infections due to susceptible organisms on or after Study Day 4 (a minimum of 7 IV doses required if randomized to ceftaroline.)"
Investigational Site, Long Beach
Investigational Site, Oakland
Investigational Site, Orange
Investigational Site, San Diego
Investigational Site, Boston
Investigational Site, Syracuse
Investigational Site, Cleveland
Investigational Site, Toledo
Investigational Site, Pittsuburg
Investigational Site, Memphis
Investigational Site, Houston
Investigational Site, Salt Lake City
Investigational Site, Morgantown
Investigational Site, Capital Federal
Investigational Site, Córdoba
Investigational Site, Plovdiv
Investigational Site, Rousse
Investigational Site2, Sofia
Investigational Site, Sofia
Investigational Site2, Tbilisi
Investigational Site3, Tbilisi
Investigational Site, Tbilisi
Investigational Site, Athens
Investigational Site, Heraklion
Investigational Site, Thessaloniki
Investigational Site, Larissa
Investigational Site, Gyula
Investigational Site, Ajka
Investigational Site, Budapest
Investigational Site, Nagykanisza
Investigational Site, Nyíregyháza
Investigational Site, Szeged
Investigational Site, Veszprém
Investigational Site, Zalaegerszeg
Investigational Site, Lublin
Investigational Site, Rzeszów
Investigational Site, Warsaw
Investigational Site, Madrid
Investigational Site, Córdoba
Investigational Site, Donetsk
Investigational Site, Ivano-Frankivsk
Investigational Site, Kryvyi Rih
Investigational Site, Kyiv
Investigational Site, Zaporizhia
Lead Sponsor
Collaborators (1)
AstraZeneca
INDUSTRY
Forest Laboratories
INDUSTRY